Searched for
ANTI COVID REGULATIONS
Disciplined investing delivered good results for us: Navneet Munot, HDFC MF CEOHDFC MF’s Navneet Munot tells Sanket Dhanorkar and Kayezad E. Adajania how navigating crises has shaped investing discipline, risk manageme...- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Diabetes drug Metformin you pop every morning not just impacts blood sugar level, but also affects your brainDiabetes drug Metformin not just impacts your blood sugar level but also affects your brain activity by shutting down a protein called Rap1...
- India waives Covid tests for flyers from China & 5 other nationsThe regulations were made for overseas travellers arriving from or passing through China, Singapore, Hong Kong, the Republic of Korea, Thai...
- China cracks down on drug price gouging amid fears of COVID spikeChina announced 10 measures on Wednesday that loosened key parts of President Xi Jinping's signature zero-COVID policy, in a dramatic pivot...
- China's zero Covid policy: What is it actually? Read to knowProtests have erupted across China in response to the government's stringent restrictions to control the spread of coronavirus.
- Themis Medi bets big on antiviral drug for CovidThemis had launched inosine pranobex under brand name Viralex in June this year. Despite the drug not figuring in the government's Covid tr...
- Do Molnupiravir's benefits outweigh risks? Here's what experts sayThe ICMR Director-General Balram Bhargava had said that molnupiravir has major safety concerns and has not been included in the national pr...
- Europe eyes arthritis drug for Covid-19 casesEU drug regulator said that it was assessing an application to extend the use of tocilizumab for adults suffering from severe coronavirus i...
- Interim data from study supports Favipiravir's safety, effectiveness: GlenmarkThe study, commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.
- Rahul Gandhi writes to PM, demands withdrawal of new regulations in LakshadweepThe Congress has been demanding the immediate recall of the Lakshadweep administrator, who it says is a politician and not a bureaucrat.
- Roche reports promising results from anti-Covid cocktailThe results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...
- Govt should commence with COVID-19 vaccination after making concrete arrangements: Akhilesh YadavYadav had on Saturday termed the anti-Covid vaccine to be rolled out in the country as a "vaccine of the BJP" and said he would not take th...
- Mayawati welcomes approval for COVID-19 vaccineRegulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of...
- Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak: Minister Vij“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...
- CCI adopting multi-pronged approach; competition law flexible to deal with challenges: Ashok Kumar GuptaFair trade regulator CCI is adopting a multi-pronged approach, including nudging entities to desist from anti-competitive practices, to ens...
- US pharma giant seeks marketing authorisation from India for remdesivir"Gilead Sciences has applied seeking marketing authorisation for its anti-viral drug remdesivir to India's Central Drugs Standard Control O...
- Govt clamps down on misleading ayurveda adsThe Ministry of Ayush has written to all states and the Advertising Standards Council of India (ASCI) to report and take action against mis...
- COVID-19: Orders for over 10 crore anti-malarial hydroxychloroquine tablets placed by CentreThe Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirm...
- CCI suspends combination, anti-competitive business practices filings till March 31In a notice, the fair trade regulator said all filings related to anti-competitive agreements and abuse of dominant positions (Sections 3 a...
Load More
